MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
T2 Biosystems Total Current Liabilities 2011-2026 | TTOO
Annual Total Current Liabilities T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.2 M | 10.1 M | 11.7 M | 9.8 M | 60.6 M | 52.3 M | 51.8 M | 9.88 M | 12.3 M | 5.17 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60.6 M | 5.17 M | 28 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.65 | - | $ 179 M |  China |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 23.91 | -3.18 % | $ 664 M |  USA |
 |
Agilent Technologies
A
|
1.71 B | $ 111.9 | -2.59 % | $ 34 B | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.07 | -2.89 % | $ 1.97 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 1.58 | -3.31 % | $ 2.1 M | USA |
 |
Personalis
PSNL
|
31.1 M | $ 5.16 | -6.18 % | $ 306 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 20.0 | -8.74 % | $ 1.07 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 14.83 | -3.07 % | $ 448 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 122.47 | -3.51 % | $ 19.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 165.5 | -0.77 % | $ 8.2 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 57.41 | -2.95 % | $ 3.43 B | USA |
 |
Guardant Health
GH
|
303 M | $ 81.21 | -2.26 % | $ 10.2 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 81.06 | -2.98 % | $ 5.47 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.96 | 1.5 % | $ 8.67 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.79 | -5.43 % | $ 283 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 412.32 | 0.62 % | $ 11.9 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.16 | -1.02 % | $ 4.96 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 115.57 | 12.76 % | $ 9.53 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 253.92 | -2.18 % | $ 21.1 B | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 8.48 | -5.99 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 119.58 | -0.41 % | $ 5.59 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 15.61 | -7.3 % | $ 349 M | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.63 | -4.34 % | $ 429 M | USA |
 |
Natera
NTRA
|
310 M | $ 193.42 | -3.37 % | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 188.44 | -3.39 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | USA |
 |
Organovo Holdings
ONVO
|
3.74 M | - | -2.3 % | $ 19.4 M | USA |